Objectives: The purpose of this study was to determine the effect of beta-blocker therapy on
outcomes of hospitalized heart failure (HF) patients enrolled in the Evaluation Study of …

Objectives: This study ascertains the relationship between continuation or withdrawal of beta-
blocker therapy and clinical outcomes in patients hospitalized with systolic heart failure (HF) …

BACKGROUND: The objective of this study was to prospectively evaluate beta-blocker use
at hospital discharge as an indicator of quality of care and outcomes in patients with heart …

Heart failure (HF) guidelines recommend that β blockers be titrated to achieve the target
doses shown to be effective in major clinical trials, if tolerated. Little is known, however …

BACKGROUND: Underutilization of β-blockers in heart failure (HF) has been widely
reported at hospital discharge and in the ambulatory setting. We examined recent temporal …

Background: Previous studies demonstrated that β-blocker use at the time of hospital
discharge significantly increased postdischarge treatment rates, associated with an early (60 …

Background It remains unclear whether beta‐blocker use at hospital admission is
associated with better in‐hospital outcomes in patients with acute decompensated heart …

Objectives: We sought to examine associations between initiation of beta-blocker therapy
and outcomes among elderly patients hospitalized for heart failure. Background: Beta …

BACKGROUND: The importance of heart failure with preserved ejection fraction is being
increasingly recognized. However, there is a paucity of data about effective treatment for this …

Background β-Blockers substantially improve survival in patients with chronic heart failure
(HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse …